AB Science S.A. (ABSCF) News Nov 13, 2014, 8:10 p.
Post# of 250675
Posted On: 11/17/2014 1:58:23 AM
AB Science S.A. (ABSCF) News Nov 13, 2014, 8:10 p.m.
MarketWatch News on ABSCF
No News currently available for ABSCF
Advertisement
Other News on ABSCF
No News currently available for ABSCF
Press Releases on ABSCF
AB Science: The Data and Safety Monitoring Board recommends the continuation of the phase 2 study with masitinib in advanced hepatocellular carcinoma 11:51 a.m. Nov. 12, 2014 - GlobeNewswire
AB Science : Web conference on Masitinib in mastocytosis 11:53 a.m. Oct. 31, 2014 - GlobeNewswire
AB Science: initiation of a new phase 3 study with masitinib in Prostate Cancer, following encouraging survival results obtained in a phase 2 study 12:10 p.m. Feb. 20, 2014 - GlobeNewswire
AB Science announces initiation of a new phase 3 study in oncology with masitinib in patients with metastatic colorectal cancer 12:32 p.m. Dec. 2, 2013 - GlobeNewswire
AB Science: Masitinib successfully passes futility analysis in pivotal clinical study in Mastocytosis 12:03 p.m. Nov. 11, 2013 - GlobeNewswire
Acceleration of Clinical Program in Amyotrophic Lateral Sclerosis (ALS) Confirms the Proof of Efficacy Data Obtained in Animals 1:26 p.m. Nov. 6, 2013 - GlobeNewswire
AB Science : Financial Results and Key Events of First Half-Year 2013 12:58 p.m. Aug. 30, 2013 - Marketwire
AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer's Disease 2:41 a.m. July 23, 2013 - Marketwire
AB Science Issues 2 Convertible Bonds for a Total Amount of 12.5 M EUR 1:04 p.m. June 10, 2013 - Marketwire
MarketWatch News on ABSCF
No News currently available for ABSCF
Advertisement
Other News on ABSCF
No News currently available for ABSCF
Press Releases on ABSCF
AB Science: The Data and Safety Monitoring Board recommends the continuation of the phase 2 study with masitinib in advanced hepatocellular carcinoma 11:51 a.m. Nov. 12, 2014 - GlobeNewswire
AB Science : Web conference on Masitinib in mastocytosis 11:53 a.m. Oct. 31, 2014 - GlobeNewswire
AB Science: initiation of a new phase 3 study with masitinib in Prostate Cancer, following encouraging survival results obtained in a phase 2 study 12:10 p.m. Feb. 20, 2014 - GlobeNewswire
AB Science announces initiation of a new phase 3 study in oncology with masitinib in patients with metastatic colorectal cancer 12:32 p.m. Dec. 2, 2013 - GlobeNewswire
AB Science: Masitinib successfully passes futility analysis in pivotal clinical study in Mastocytosis 12:03 p.m. Nov. 11, 2013 - GlobeNewswire
Acceleration of Clinical Program in Amyotrophic Lateral Sclerosis (ALS) Confirms the Proof of Efficacy Data Obtained in Animals 1:26 p.m. Nov. 6, 2013 - GlobeNewswire
AB Science : Financial Results and Key Events of First Half-Year 2013 12:58 p.m. Aug. 30, 2013 - Marketwire
AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer's Disease 2:41 a.m. July 23, 2013 - Marketwire
AB Science Issues 2 Convertible Bonds for a Total Amount of 12.5 M EUR 1:04 p.m. June 10, 2013 - Marketwire
(0)
(0)